Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.7.0.1
Equity (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2017
Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Shares, Outstanding Balance 510,000  
Number of Shares, Granted 20,000  
Number of Shares, Outstanding Balance 530,000 510,000
Number of Shares, Exercisable 50,000  
Weighted Average Grant Date Fair Value, Outstanding Balance $ 3.40  
Weighted Average Grant Date Fair Value, Granted 1.76  
Weighted Average Grant Date Fair Value, Outstanding Balance 3.33 $ 3.40
Weighted Average Grant Date Fair Value, Exercisable 0.14  
Weighted Average Exercise Price, Outstanding Balance 5.28  
Weighted Average Exercise Price, Granted 2.31  
Weighted Average Exercise Price, Outstanding Balance 5.17 $ 5.28
Weighted Average Exercise Price, Exercisable $ 0.20  
Weighted Average Remaining Contractual Term (in years), Outstanding 8 years 6 months 25 days 9 years 3 months 14 days
Weighted Average Remaining Contractual Term (in years), Exercisable 2 years 11 months 1 day  
Aggregate Intrinsic Value, Outstanding Balance $ 83,500 $ 48,500
Aggregate Intrinsic Value, Exercisable $ 83,500